The Financial Express3h
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Science Daily10h
Diabetes can drive the evolution of antibiotic resistance
Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
Daily Excelsior11h
Dr Jitendra Addresses ‘World Diabetes Congress’, Calls For Mass Prevention Campaign
AHMEDABAD, Feb 15 : Union Minister Dr. Jitendra Singh today emphasized that Type 2 Diabetes Mellitus is no longer just a ...
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
Program designed by and for Aboriginal women sees 30% diabetes remission in participants
An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and measured how using Shared Medical Appointments, continuous glucose monitors ...